+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pediatric Interventional Cardiology Market, Size, Forecast 2022-2027, Industry Trends, Share, Growth, Impact of COVID-19, Company Analysis

  • PDF Icon

    Report

  • 100 Pages
  • April 2022
  • Region: Global
  • Renub Research
  • ID: 5576813
Global Pediatric Interventional Cardiology Market is estimated to reach US$ 2,190.1 Million by 2027. Pediatric interventional cardiology is a sub-specialty of cardiology that focuses on using particular catheter-based procedures to treat cardiac problems in newborns, children, and adolescents up to the age of 18. Balloon angioplasty, coil occlusion, stent implantation, and aortic valve stenosis are some of the procedures available. In addition, as compared to traditional cardiology procedures, pediatric interventional cardiology is less invasive, resulting in fewer post-surgery problems. Hence, they are widely utilized to perform angioplasty, valvuloplasty, coronary thrombectomy, and congenital heart defect corrective treatments.



Global Pediatric Interventional Cardiology Industry is anticipated to expand at a CAGR of 6.39% during 2021-2027:


The global Pediatric Interventional Cardiology Market Size is expanding rapidly, owing to a growth in the number of children with cardiac disorders and technical breakthroughs in the area. The worldwide pediatric interventional cardiology devices demand is also being driven by the increased incidence of congenital cardiac diseases and government initiatives in this field. In addition, the worldwide pediatric interventional cardiology devices market is benefiting from rising awareness and popularity of more minor invasive procedures.

Congenital Heart Defect Closure Devices and Transcatheter Heart Valves are significant segments:


By Device Type, the dominance of congenital heart defect closure devices in the pediatric interventional cardiology market is due to an increase in the number of cases of congenital disabilities and increased awareness of the necessity for pediatric interventional cardiology devices. Furthermore, because cardiac procedures involving transcatheter heart valves are more effective, the market for transcatheter heart valves is predicted to develop at a constant rate throughout the forecast period.

The Hospitals Segment Dominates the Market for Global Pediatric Interventional Cardiology Devices:


The hospital segment will lead the Paediatric Interventional Cardiology Devices market in 2021 and beyond. The domination of hospitals can be attributed to well-equipped infrastructure, the availability of technical equipment, an increase in the number of practitioners and patients, and an increase in collaborations to help alleviate the load of diagnosis and treatment around the world.

In addition, the availability of sophisticated technology to monitor pediatric cardiac abnormalities and a change in attention toward ambulatory centers for treatment has increased the number of patients choosing mobile facilities for diagnosis. As a result, there is an association between ambulatory center expansion and ambulatory center growth.

North America Dominates the Global Paediatric Interventional Cardiology Devices Industry:


According to the research, North America dominates the global pediatric interventional cardiology devices market, owing to the rising frequency of cardiac illnesses among children and the region's technical improvement. In the next few years, the pediatric interventional cardiology devices market in Asia-Pacific is predicted to rise rapidly.

In the Asian region, China and India are expected to be the fastest expanding markets for pediatric interventional cardiology devices. This is due to massive investments in these countries by various multinational corporations. Large patient pools, increased government funding, and improved healthcare facilities are the primary driving forces for emerging countries' pediatric interventional cardiology devices market.

Key Players:


The international market for pediatric interventional cardiology is highly consolidated, oligopolistic, and competitive. Furthermore, the market is capital-intensive, necessitating significant investments in R&D initiatives. The global pediatric interventional cardiology market is monopolized by Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V.

Furthermore, these market participants in the Global Pediatric Interventional Cardiology Industry are focusing on expanding their product portfolios through inorganic growth strategies including acquisitions, mergers, and collaborations.

How COVID-19 Turned Down the Global Paediatric Interventional Cardiology Market:


The COVID-19 pandemic significantly impacted pediatric cardiac care worldwide, resulting in fewer hospitalizations and cardiac operations. Thus, in a resource-constrained setting, such a considerable reduction in the number of procedures had a significant impact. However, the recovery and vaccine data have shown to be valuable in establishing a strategy to manage the COVID-19 pandemic's future effects. Thus, as per the analysis, Global Paediatric Interventional Cardiology Market was US$ 1,510.3 Million in 2021.

The publisher's latest report Paediatric Interventional Cardiology Market, Global Forecast By Device Type (Congenital Heart Defect Closure Devices and Transcatheter Heart Valves), End Use (Hospitals, Ambulatory Surgical Centers, Specialty Clinic), Region (North America, Europe, Asia Pacific and Middle East & Africa), Companies (Cardinal Health Inc., Medtronic Inc., Abbott Laboratories, Boston Scientific Corporation, General Electric, Siemens AG, and Koninklijke Philips N.V)” provides a detailed analysis of Paediatric Interventional Cardiology Industry.

Device Type - Market has been covered from 2 viewpoints:


1. Congenital Heart Defect Closure Devices
2. Transcatheter Heart Valves

End Use - Market has been covered from 3 viewpoints:


1. Hospitals
2. Ambulatory Surgical Centers
3. Specialty Clinic

Region - Market has been covered from 4 viewpoints:


1. North America
2. Europe
3. Asia Pacific
4. Middle East & Africa

Company Insights:


  • Overview
  • Recent Development & Strategies
  • Financial Insights

Companies Covered:


1. Cardinal Health Inc.
2. Medtronic, Inc.
3. Abbott Laboratories
4. Boston Scientific Corporation
5. General Electric
6. Siemens AG
7. Koninklijke Philips N.V
Frequently Asked Questions about the Global Pediatric Interventional Cardiology Market

What is the estimated value of the Global Pediatric Interventional Cardiology Market?

The Global Pediatric Interventional Cardiology Market was estimated to be valued at $1510.3 Million in 2021.

What is the growth rate of the Global Pediatric Interventional Cardiology Market?

The growth rate of the Global Pediatric Interventional Cardiology Market is 6.3%, with an estimated value of $2190.1 Million by 2027.

What is the forecasted size of the Global Pediatric Interventional Cardiology Market?

The Global Pediatric Interventional Cardiology Market is estimated to be worth $2190.1 Million by 2027.

Table of Contents

1. Introduction2. Research & Methodology3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Global Pediatric Interventional Cardiology Market
6. Market Share - Global Pediatric Interventional Cardiology Market
6.1 By Device Type
6.2 By End Use
6.3 By Region
7. Device Type - Global Pediatric Interventional Cardiology Market
7.1 Congenital Heart Defect Closure Devices
7.2 Transcatheter Heart Valves
8. End Use - Global Pediatric Interventional Cardiology Market
8.1 Hospitals
8.2 Ambulatory Surgical Centers
8.3 Specialty Clinic
9. Region - Global Pediatric Interventional Cardiology Market
9.1 North America
9.2 Europe
9.3 Asia Pacific
9.4 Middle East & Africa
10. Porters Five Forces
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Competition
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. Company Analysis
11.1 Cardinal Health Inc.
11.1.1 Overview
11.1.2 Recent Development
11.1.3 Financial Insights
11.2 Medtronic, Inc.
11.2.1 Overview
11.2.2 Recent Development
11.2.3 Financial Insights
11.3 Abbott Laboratories
11.3.1 Overview
11.3.2 Recent Development
11.3.3 Financial Insights
11.4 Boston Scientific Corporation
11.4.1 Overview
11.4.2 Recent Development
11.4.3 Financial Insights
11.5 General Electric
11.5.1 Overview
11.5.2 Recent Development
11.5.3 Financial Insights
11.6 Siemens AG
11.6.1 Overview
11.6.2 Recent Development
11.6.3 Financial Insights
11.7 Koninklijke Philips N.V
11.7.1 Overview
11.7.2 Recent Development
11.7.3 Financial Insights
List of Figures:
Figure 01: Global - Pediatric Interventional Cardiology Market (Million US$), 2016 - 2021
Figure 02: Global - Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 - 2027
Figure 03: Device Type - Congenital Heart Defect Closure Devices Market (Million US$), 2016 - 2021
Figure 04: Device Type - Forecast for Congenital Heart Defect Closure Devices Market (Million US$), 2022 - 2027
Figure 05: Device Type - Transcatheter Heart Valves Market (Million US$), 2016 - 2021
Figure 06: Device Type - Forecast for Transcatheter Heart Valves Market (Million US$), 2022 - 2027
Figure 07: End Use - Hospitals Market (Million US$), 2016 - 2021
Figure 08: End Use - Forecast for Hospitals Market (Million US$), 2022 - 2027
Figure 09: End Use - Ambulatory Surgical Centers Market (Million US$), 2016 - 2021
Figure 10: End Use - Forecast for Ambulatory Surgical Centers Market (Million US$), 2022 - 2027
Figure 11: End Use - Specialty Clinic Market (Million US$), 2016 - 2021
Figure 12: End Use - Forecast for Specialty Clinic Market (Million US$), 2022 - 2027
Figure 13: North America - Pediatric Interventional Cardiology Market (Million US$), 2016 - 2021
Figure 14: North America - Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 - 2027
Figure 15: Europe - Pediatric Interventional Cardiology Market (Million US$), 2016 - 2021
Figure 16: Europe - Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 - 2027
Figure 17: Asia Pacific - Pediatric Interventional Cardiology Market (Million US$), 2016 - 2021
Figure 18: Asia Pacific - Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 - 2027
Figure 19: Middle East & Africa - Pediatric Interventional Cardiology Market (Million US$), 2016 - 2021
Figure 20: Middle East & Africa - Forecast for Pediatric Interventional Cardiology Market (Million US$), 2022 - 2027
Figure 21: Cardinal Health Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 22: Cardinal Health Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 23: Medtronic, Inc. - Global Revenue (Million US$), 2016 - 2021
Figure 24: Medtronic, Inc. - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 25: Abbott Laboratories - Global Revenue (Million US$), 2016 - 2021
Figure 26: Abbott Laboratories - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 27: Boston Scientific Corporation - Global Revenue (Million US$), 2016 - 2021
Figure 28: Boston Scientific Corporation - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 29: General Electric - Global Revenue (Million US$), 2016 - 2021
Figure 30: General Electric - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 31: Siemens AG - Global Revenue (Million US$), 2016 - 2021
Figure 32: Siemens AG - Forecast for Global Revenue (Million US$), 2022 - 2027
Figure 33: Koninklijke Philips N.V - Global Revenue (Million US$), 2016 - 2021
Figure 34: Koninklijke Philips N.V - Forecast for Global Revenue (Million US$), 2022 - 2027
List of Tables:
Table 01: Global - Pediatric Interventional Cardiology Market Share by Device Type (Percent), 2016 - 2021
Table 02: Global - Forecast for Pediatric Interventional Cardiology Market Share by Device Type (Percent), 2022 - 2027
Table 03: Global - Pediatric Interventional Cardiology Market Share by End User (Percent), 2016 - 2021
Table 04: Global - Forecast for Pediatric Interventional Cardiology Market Share by End User (Percent), 2022 - 2027
Table 05: Global - Pediatric Interventional Cardiology Market Share by Region (Percent), 2016 - 2021
Table 06: Global - Forecast for Pediatric Interventional Cardiology Market Share by Region (Percent), 2022 - 2027

Companies Mentioned

  • Cardinal Health Inc.
  • Medtronic, Inc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • General Electric
  • Siemens AG
  • Koninklijke Philips N.V

Methodology

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...